Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print UT School of Public Health researchers discover significant efficacy of travelers' diarrhea vaccine

UT School of Public Health researchers discover significant efficacy of travelers' diarrhea vaccine

June 12, 2008

Researchers at The University of Texas School of Public Health have found that patients given a travelers' diarrhea vaccine were significantly less likely to suffer from clinically significant diarrhea than those who received placebo, according to a study published in this week's edition of the Lancet. The patch-based vaccine is part of the Phase 2 study in conjunction with the Iomai Corporation.

The study, which followed 170 healthy travelers ages 18-64 to Mexico and Guatemala, found that of the 59 individuals who received the novel vaccine, only three suffered from moderate or severe diarrhea, while roughly two dozen of the 111 who received a placebo suffered from moderate or severe diarrhea. Only one of the 59 volunteers in the vaccine group reported severe diarrhea, compared with 12 in the placebo group.




"These results suggest that the Iomai patch has the potential to fundamentally change the way we approach prevention of this disease, an ailment against which we now have very few weapons," said Herbert L. DuPont, M.D., professor and director of the Center for Infectious Diseases at The University of Texas School of Public Health and the principal investigator of the trial. "If these results are replicated, the Iomai vaccine will have the potential to not only mitigate a disease that sickens millions each year but also keep some patients from going on to develop the chronic symptoms of irritable bowel syndrome."

The Trek Study was done in collaboration with UT Houston, the Johns Hopkins Bloomberg School of Public Health and other institutions. Each volunteer received either two doses of the vaccine patch or a placebo, 2 to 3 weeks apart, with the last dose administered a week before travel. Travelers kept detailed diaries and received in-country checkups. The study was designed to evaluate the safety of the vaccine and the incidence of enterotoxigenic E. coli (ETEC) bacteria - the most common cause of travelers' diarrhea. No vaccine-related serious side effects were reported.

Of the few vaccinated patients who became sick, the diarrhea lasted only half a day on average, while those in the placebo group endured two days of illness and more than twice as many loose stools. Although not statistically significant, the frequency of new-onset irritable bowel syndrome, a long-term consequence of travelers' diarrhea, was three times greater in placebo than vaccine recipients.

This year, approximately 55 million international travelers will visit countries where bacteria that cause travelers' diarrhea are endemic, particularly Africa, Asia and Latin America, and about 20 million of those will develop travelers' diarrhea.

In addition to the acute symptoms of travelers' diarrhea, which include severe diarrhea, abdominal cramps and dehydration, patients who suffer a bout of travelers' diarrhea are also at higher risk of developing irritable bowel syndrome, a chronic condition characterized by pain, bloating, diarrhea or constipation. Diarrheal disease also exacts a significant toll on children in the developing world, where diarrhea linked to enterotoxigenic E. sickens 210 million children each year, killing an estimated 380,000 annually.

"Bacterial diarrheal disease is a significant medical problem both for children and travelers, and our technology represents both an advance in vaccine delivery and a breakthrough in the field of infectious disease," said Gregory Glenn, M.D., Iomai's chief scientific officer. "We look forward to targeting both the significant travelers' market and developing the vaccine for the children in the developing world who still suffer serious morbidity and mortality from this disease."

Iomai plans to initiate a Phase 3 program for the needle-free vaccine patch vaccine in 2009. If approved, the Iomai vaccine would be the first vaccine for travelers' diarrhea available in the United States.

University of Texas Health Science Center at Houston



Related Diarrhea Current Events and Diarrhea News Articles Diarrhea Current Events and Diarrhea News RSS Diarrhea Current Events and Diarrhea News RSS
Genetic mutation causes familial susceptibility for degenerative brain disease
Mutation of a gene that helps proteins migrate in and out of the cell's genetic command center - the nucleus - puts some families at higher risk for the degenerative brain disease acute necrotizing encephalopathy (ANE).

Old gastrointestinal drug slows aging, McGill researchers say
Recent animal studies have shown that clioquinol - an 80-year old drug once used to treat diarrhea and other gastrointestinal disorders - can reverse the progression of Alzheimer's, Parkinson's and Huntington's diseases.

New genetic markers for ulcerative colitis identified, researchers report in Nature Genetics
An international team led by University of Pittsburgh School of Medicine researchers has identified genetic markers associated with risk for ulcerative colitis.

New study shows that a cough medicine ingredient could effectively treat prostate cancer
A study published today in the December issue of the European medical journal Anticancer Research demonstrates that an ingredient used in a common cough suppressant may be useful in treating advanced prostate cancer.

Einstein researchers find convincing evidence that probiotics are effective
Up to one in five people on antibiotics stop taking their full course of antibiotic therapy due to diarrhea. Physicians could help patients avoid this problem by prescribing probiotics, according to a study by researchers at Albert Einstein College of Medicine of Yeshiva University published in American Family Physician.

Iressa proves just as effective as chemotherapy for lung cancer
Gefitinib, also known as Iressa, the once-promising targeted therapy for the treatment of non-small cell lung cancer, has proven as effective as chemotherapy as a second-line therapy for the disease with far fewer side effects, according to an international Phase III clinical trial, led by researchers at The University of Texas M. D. Anderson Cancer Center.

Adalimumab may reduce health-care costs for Crohn's disease patients
Inflammatory bowel disease (IBD) is a term that refers to both ulcerative colitis (UC) and Crohn's disease (CD). IBD occurs most frequently in people in their late teens and twenties. There have been cases in children as young as two years old and in older adults in their seventies and eighties; men and women have an equal chance of getting the disease.

Tibotec presents interim findings for TMC435, an investigational genotype 1 hepatitis C treatment
New clinical data show antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed by Tibotec BVBA for the treatment of chronic hepatitis C virus (HCV) infection.

A rare case of collagenous colitis presenting as protein-losing enteropathy
Since the first report in 1976, collagenous colitis has been associated with a variety of conditions, including use of non-steroidal anti-inflammatory drugs and proton pump inhibitors.

Pakistan introduces vaccine to prevent top child killer
This month, Pakistan is introducing a new combination vaccine that will protect its children against the bacterium Haemophilus influenzae type b (Hib) and four other common childhood diseases.
More Diarrhea Current Events and Diarrhea News Articles


Bovine Viral Diarrhea Virus: Diagnosis, Management,and Control

For almost 60 years, continual research on the subject of Bovine Viral Diarrhea (BVD) has raised as many questions as that research has answered. This common disease continues to cause sickness, death, abortion and fetal anomalies despite the millions of vaccination doses used each year to prevent its spread. Written by international experts on the subject of the BVD virus, BVDV: Diagnosis,...



The Complete Guide to Digestive Health: Plain Answers about IBS, Constipation, Diarrhea, Heartburn, Ulcers and More

For those who frequently or even occasionally suffer from digestive problems here is a book offering natural ways to fight all types of intestinal ailments, without risky surgery or dangerous drugs. Using carefully researched information about proven natural remedies, The Complete Guide to Digestive Health provides valuable, practical health information. Whether a person suffers from heartburn,...



The Complete Guide to Digestive Health: Plain Answers About IBS, Constipation, Diarrhea, Heartburn, Ulcers, and More
by Gayle K. Wood

For those who frequently or even occasionally suffer from digestive problems here is a book offering natural ways to fight all types of intestinal ailments, without risky surgery or dangerous drugs. Using carefully researched information about proven natural remedies, The Complete Guide to Digestive Health provides valuable, practical health information. Whether a person suffers from heartburn,...



Diarrhea
by Brandy Lynn McDevitt

Diarrhea. When you see this word on a book's cover, your view of the book may be a little distorted. When you open this book and read, you will learn about Brandy through the ups and downs of her life. Then you will see that the human mind can conquer anything. Brandy grew up without a mother. She had a father who worked nonstop to give her everything she desired. She has matured into a happy,...

The Complete Guide to Digestive Health: Plain Answers About IBS, Constipation, Diarrhea, Heartburn, Ulcers and More



Traveller's Diarrhea
by Charles D. Ericsson MD; Herbert L. Dupont ; Robert Steffen

Charles D. Ericsson, MD, Herbert L. DuPont, MD, Robert Steffen, MD Travelers Diarrhea aims to convey a thorough history, a basic understanding of the discipline, state-of-the-art management recommendations and thoughts for future research. Substantial understanding of the risks of acquiring travelers diarrhea exists and we continue to learn about differences in host susceptibility. Recent...



Gut Help: Guide to Breaking Free of IBD and IBS
by Stephen Demirjian

Now an official selection of the Crohn's and Colitis Foundation of America. An inspirational reference for anyone struggling with IBD (Crohn's, colitis) or IBS (Irritable Bowel Syndrome), Demirjian documents his successful effort to break free of ulcerative colitis without surgery. In an honest and uplifting tone, he reveals valuable insight into living a better quality life, as well as his Gut...



Living with IBD & IBS: A Personal Journey of Success
by Elizabeth A Roberts

You may not think anything about IBD or IBS is funny, until you read Elizabeth Roberts’ account of her emotional roller-coaster ride as she learned to live successfully with these illnesses. After spending most of her honeymoon on St. Bart’s in the bathroom, Roberts returned home determined to find out what had happened to her dream life. After months of tests, her doctors told her she had...



Mayo Clinic on Digestive Health, Second Edition

(Mayo Clinic) Mayo Clinic, Rochester, MN. Practical consumer text offers proven strategies for managing common digestive problems, including gas, heartburn, ulcers, constipation, and diarrhea. Also addresses irritable bowel syndrome, celiac disease, colorectal cancer, and more. Practical tips are included throughout. Previous edition: c2000....



Diarrhea (Telford Press)
by Michael Gracey

This book helps bring the busy practitioner up to date with recent developments in research on diarrhea that has taken place over the past 10 years. The causes of diarrhea are very diverse and include infections, allergies, chronic inflammatory diseases, tumors and inborn errors of intestinal digestion and transport. The global importance of diarrheal deaths and illnessess, as well as the rapid...

© 2009 BrightSurf.com